Jakarta –
The Polymerase Chain Reaction (PCR) polemic, which has been mentioned as a business activity behind the COVID-19 pandemic, was dismantled by the Business Competition Supervisory Commission (KPPU). KPPU studied the PCR industry including holding discussions with various parties including BPKP, Persi, Gakeslab, ILKI, ICW and others.
KPPU’s Director of Economics, Mulyawan Ranamanggala, admitted that there were several parties who took advantage of the PCR policy for profit. This is done through the practice of bundling PCR tests, combining a service with PCR tests.
“We see that this is an indication of maximizing profits when there was PCR bundling,” said Mulyawan in a virtual journalist forum, quoted on Sunday (11/14/2021).
For example, he linked a doctor’s examination consulting service that also provides PCR test services. Well, the price that must be spent for PCR, he said, is usually more expensive or even twice the market price.
“When there is a PCR test that is bundled with consulting services with doctors, for example. He (PCR rates) will increase the price to double,” said Mulyawan.
He considered, this kind of practice is a form of unfair business competition. Especially when the PCR test is used to check for COVID-19, it is actually used to make a profit.
“Bundling like this raises the potential for unfair business competition, the essence of PCR is to prove whether the person is infected with the Corona virus or not. Not to be part of the business,” said Mulyawan.
Continue reading –>
Watch Videos”Looking at the Journey of PCR Test Prices: The Beginning of a Millions Pandemic, Now IDR 275 Thousand“
[Gambas:Video 20detik]
– .
